Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Yutaka Tojo"'
Autor:
Shinya Ohkouchi,, Manabu Ono, Makoto Kobayashi, Taizou Hirano, Yutaka Tojo, Shu Hisata, Masakazu Ichinose, Toshiya Irokawa, Hiromasa Ogawa, Hajime Kurosawa
Publikováno v:
Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 2015, Iss Suppl. 1, Pp 91-96 (2015)
Externí odkaz:
https://doaj.org/article/a727d2192ac343d3afa11e0a8757840b
Publikováno v:
International Journal of Infectious Diseases, Vol 67, Iss C, Pp 41-42 (2018)
Externí odkaz:
https://doaj.org/article/81ddc08a0825423f8569bf4cc49ffcfd
Autor:
Akira Horii, Ming-Sound Tsao, Masakazu Ichinose, Masao Nagasaki, Seiichi Kobayashi, Naoto Ishii, Tadashi Ishii, Yoshinori Okada, Ming Li, Nhu-An Pham, Akira Sakurada, Michiaki Abe, Riu Yamashita, Yutaka Tojo, Ryota Saito, Takahiro Mimori, Atsuko Asao, Tetsuya Akaishi, Shinichi Fukushige, Eisaku Miyauchi, Yuriko Saiki, Mie Yamanaka, Kota Ishizawa
Purpose:The epithelial-to-mesenchymal transition, the major process by which some cancer cells convert from an epithelial phenotype to a mesenchymal one, has been suggested to drive chemo-resistance and/or metastasis in patients with cancer. However,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f82d4b54d7ba83b57c34fb6cf388012
https://doi.org/10.1158/1078-0432.c.6529109.v1
https://doi.org/10.1158/1078-0432.c.6529109.v1
Autor:
Akira Horii, Ming-Sound Tsao, Masakazu Ichinose, Masao Nagasaki, Seiichi Kobayashi, Naoto Ishii, Tadashi Ishii, Yoshinori Okada, Ming Li, Nhu-An Pham, Akira Sakurada, Michiaki Abe, Riu Yamashita, Yutaka Tojo, Ryota Saito, Takahiro Mimori, Atsuko Asao, Tetsuya Akaishi, Shinichi Fukushige, Eisaku Miyauchi, Yuriko Saiki, Mie Yamanaka, Kota Ishizawa
Table S1. Patients' characteristics analyzed in this study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3c4f7643acc4a0e0dac2d66a58c2b2
https://doi.org/10.1158/1078-0432.22475594
https://doi.org/10.1158/1078-0432.22475594
Autor:
Akira Horii, Ming-Sound Tsao, Masakazu Ichinose, Masao Nagasaki, Seiichi Kobayashi, Naoto Ishii, Tadashi Ishii, Yoshinori Okada, Ming Li, Nhu-An Pham, Akira Sakurada, Michiaki Abe, Riu Yamashita, Yutaka Tojo, Ryota Saito, Takahiro Mimori, Atsuko Asao, Tetsuya Akaishi, Shinichi Fukushige, Eisaku Miyauchi, Yuriko Saiki, Mie Yamanaka, Kota Ishizawa
Supplementary Figure S1. Genetic alterations of TP53 (exons 5 through 9) and KRAS (exon 2 containing codons 12 and 13) in Cases #1, 6, and 9 were Sanger sequenced; both strands were analyzed.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1713f62b92cfb1b9339a685c5855ce03
https://doi.org/10.1158/1078-0432.22475597
https://doi.org/10.1158/1078-0432.22475597
Autor:
Yoshinori Okada, Michiaki Abe, Riu Yamashita, Yuriko Saiki, Ming Li, Masao Nagasaki, Kota Ishizawa, Naoto Ishii, Tadashi Ishii, Mie Yamanaka, Akira Sakurada, Akira Horii, Shinichi Fukushige, Takahiro Mimori, Ming-Sound Tsao, Ryota Saito, Yutaka Tojo, Tetsuya Akaishi, Eisaku Miyauchi, Atsuko Asao, Masakazu Ichinose, Nhu An Pham, Seiichi Kobayashi
Publikováno v:
Clinical Cancer Research. 25:6756-6763
Purpose: The epithelial-to-mesenchymal transition, the major process by which some cancer cells convert from an epithelial phenotype to a mesenchymal one, has been suggested to drive chemo-resistance and/or metastasis in patients with cancer. However
Autor:
Hirohito, Sano, Teruyuki, Satou, Koji, Murakami, Yutaka, Tojo, Risa, Shibuya, Ayumi, Mitsune, Shun, Yamanaka, Tsutomu, Tamada, Hisatoshi, Sugiura, Masakazu, Ichinose
Publikováno v:
Arerugi = [Allergy]. 69(5)
We present a case of a 17-year-old woman with a history of bronchial asthma since two years of age. She had daily asthma attacks from the age of fourteen, and the addition of oral corticosteroids and omalizumab to regular inhaled corticosteroid inhal
Autor:
Mami Morita, Ayumi Mitsune, Tatsuro Fukuhara, Eisaku Miyauchi, Yutaka Tojo, Satoru Yanagisawa, Manabu Ono, Masakazu Ichinose
Publikováno v:
Internal Medicine
Nivolumab is a newly introduced promising therapy for treating lung cancer that restores the anti-tumor immunity by disrupting programmed cell death-1-mediated immuno-suppressive signaling. Although "new-onset" autoimmune diseases are well-known immu
Autor:
Kota, Ishizawa, Mie, Yamanaka, Yuriko, Saiki, Eisaku, Miyauchi, Shinichi, Fukushige, Tetsuya, Akaishi, Atsuko, Asao, Takahiro, Mimori, Ryota, Saito, Yutaka, Tojo, Riu, Yamashita, Michiaki, Abe, Akira, Sakurada, Nhu-An, Pham, Ming, Li, Yoshinori, Okada, Tadashi, Ishii, Naoto, Ishii, Seiichi, Kobayashi, Masao, Nagasaki, Masakazu, Ichinose, Ming-Sound, Tsao, Akira, Horii
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 25(22)
The epithelial-to-mesenchymal transition, the major process by which some cancer cells convert from an epithelial phenotype to a mesenchymal one, has been suggested to drive chemo-resistance and/or metastasis in patients with cancer. However, only a
Autor:
Kei Sato, Shun Yamanaka, Koji Itakura, Hirohito Sano, Akira Koarai, Yutaka Tojo, Tomohiro Ichikawa, Mitsuhiro Yamada, Tadahisa Numakura, Tsutomu Tamada, Yorihiko Kyogoku, Katsuhiro Onodera, Rie Tanaka, Takaaki Akaike, Hisatoshi Sugiura, Ayumi Mitsune, Naoya Fujino, Masakazu Ichinose
Publikováno v:
The Journal of allergy and clinical immunology. 144(4)
Background Asthma–chronic obstructive pulmonary disease overlap (ACO) has frequent exacerbations and a poor quality of life and prognosis compared with those of chronic obstructive pulmonary disease alone. However, the pathogenesis of ACO has not b